<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">The combined efforts of the scientific community, mobilization of public health resources, increased public and private investment, and a ‘completely new culture of doing research’ [
 <xref rid="bb0030" ref-type="bibr">6</xref>] accelerated the first novel vaccine candidate through discovery, lead-candidate optimization, preclinical development, and into clinical trials within 2 months of the outbreak. Four additional candidates entered the clinic within the next month and 18 more are expected to begin clinical trials by late 2020 [
 <xref rid="bb0035" ref-type="bibr">7</xref>].
</p>
